Atea Pharmaceuticals
AVIR
AVIR
130 hedge funds and large institutions have $278M invested in Atea Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.42% more ownership
Funds ownership: 69.01% → 69.43% (+0.42%)
15% less capital invested
Capital invested by funds: $327M → $278M (-$48.8M)
Holders
130
Holding in Top 10
2
Calls
$9.84M
Puts
$185K
Top Buyers
| 1 | +$2.9M | |
| 2 | +$1.51M | |
| 3 | +$1.35M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.35M |
| 5 |
RC
RBF Capital
San Francisco,
California
|
+$1.29M |
Top Sellers
| 1 | -$7.19M | |
| 2 | -$3.61M | |
| 3 | -$3.44M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.63M |